AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Clinical trial NCT00427349 · COMPLETED

Trial details

NCT number: NCT00427349
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Carcinoid Tumor Islet Cell Tumor Neoplastic Syndrome

Start date: 2008-11-07
Primary completion: 2014-10-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.